Published in J Infect Dis on March 01, 1985
Clostridium difficile-associated diarrhea in adults. CMAJ (2004) 4.27
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis (2013) 3.56
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A (2010) 1.89
Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol (1998) 1.89
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun (1994) 1.68
Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea. J Clin Microbiol (1987) 1.53
Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. J Clin Microbiol (1992) 1.49
Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks. J Clin Microbiol (1989) 1.20
Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. Eur J Clin Microbiol Infect Dis (2011) 1.18
Rectal swab cultures for Clostridium difficile surveillance studies. J Clin Microbiol (1987) 1.17
Effects of treatment with antimicrobial agents on the human colonic microflora. Ther Clin Risk Manag (2008) 1.13
Side effects of cephalosporins. Drugs (1987) 1.11
N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project. Can J Infect Dis (2001) 1.10
Clostridium difficile and the microbiota. J Clin Invest (2014) 1.09
Clostridium difficile associated diarrhoea: diagnosis and treatment. BMJ (2005) 1.09
Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother (1991) 0.97
High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS One (2012) 0.96
Postoperative Clostridium difficile-associated diarrhea. Surgery (2010) 0.95
Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrob Agents Chemother (1989) 0.92
Comparison of media for screening of diarrheic stools for the recovery of Clostridium difficile. J Clin Microbiol (1989) 0.91
Co-morbidity, not age predicts adverse outcome in clostridium difficile colitis. World J Gastroenterol (2000) 0.88
Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants. J Clin Microbiol (2013) 0.87
Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo. Antimicrob Agents Chemother (1992) 0.82
Predictors of Clostridium difficile colitis infections in hospitals. Epidemiol Infect (2007) 0.82
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis (2015) 0.82
Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol (2007) 0.80
Bile salt inhibition of host cell damage by Clostridium difficile toxins. PLoS One (2013) 0.78
Case-control analysis of clostridium difficile-associated diarrhea on a gynecologic oncology service. Infect Dis Obstet Gynecol (1994) 0.77
Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection? J Hosp Infect (2011) 0.77
Clostridium difficile in urology. Ann R Coll Surg Engl (2008) 0.75
Clostridium difficile after antibiotic therapy. Br J Gen Pract (1994) 0.75
Evaluation of five test-kits-API, AuxoTab, Enterotube, PathoTec and R-B-for identification of Enterobacteriaceae. Med Microbiol Immunol (1974) 8.61
Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. Antimicrob Agents Chemother (1976) 4.64
Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis (2001) 4.17
Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet (1982) 3.64
The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci U S A (1994) 3.02
Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli. Lancet (1981) 2.76
Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scand J Infect Dis Suppl (1979) 2.66
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis (2000) 2.37
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother (2001) 2.35
Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis. Pediatr Clin North Am (1982) 2.33
Evaluation of two test-kits--API and Oxi Ferm tube--for identification of oxidative-fermentative Gram-negative rods. Med Microbiol Immunol (1977) 2.31
Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.15
Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol (1984) 2.07
Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol (1981) 2.03
Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis (1997) 2.02
In vitro adhesion of uropathogenic Escherichia coli to human periurethral cells. Infect Immun (1980) 1.98
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother (1980) 1.95
Enterotoxin-producing bacteria and parasites in stools of Ethiopian children with diarrhoeal disease. Arch Dis Child (1976) 1.94
Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis (1993) 1.92
Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test. Infection (1982) 1.88
Purification and some properties of a heat-labile enterotoxin from escherichia coli. Zentralbl Bakteriol Orig A (1974) 1.83
Sensitive assay for detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts. Infect Immun (1975) 1.78
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Evaluation of a ganglioside immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1979) 1.70
Rapid grouping of streptococci by immunoelectroosmophoresis. Med Microbiol Immunol (1974) 1.67
Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection (1980) 1.66
Development of the faecal anaerobic microflora after caesarean section and treatment with antibiotics in newborn infants. Infection (1987) 1.66
Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother (1982) 1.65
Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis (1991) 1.65
Carbohydrate receptor structures recognized by uropathogenic E. coli. Scand J Infect Dis Suppl (1982) 1.63
Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl (1999) 1.62
Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis (1979) 1.61
Characterization of Aeromonas spp. isolated from humans with diarrhea, from healthy controls, and from surface water in Bangladesh. J Clin Microbiol (1997) 1.59
Antibody response in Staphylococcus aureus septicaemia--a prospective study. J Med Microbiol (1998) 1.58
P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection (1983) 1.57
Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis (1974) 1.57
Separation of two hemolysins from Aeromonas hydrophila by isoelectric focusing. Infect Immun (1971) 1.57
The composition of the faecal microflora in breastfed and bottle fed infants from birth to eight weeks. Acta Paediatr Scand (1985) 1.56
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis. Med Microbiol Immunol (1977) 1.55
Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis. Scand J Infect Dis (1975) 1.54
Effects of staphylococcal alpha-, beta-, delta-, and gamma-hemolysins on human diploid fibroblasts and HeLa cells: evaluation of a new quantitative as say for measuring cell damage. Infect Immun (1973) 1.54
Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). J Clin Microbiol (1987) 1.54
Aspects on antibacterial treatment of anaerobic infections. Scand J Infect Dis Suppl (1982) 1.53
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother (1999) 1.52
Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J Antimicrob Chemother (1981) 1.52
Enterotoxigenic Escherichia coli and other gram-negative bacteria of infantile diarrhea: surface antigens, hemagglutinins, colonization factor antigen, and loss of enterotoxigenicity. J Infect Dis (1980) 1.51
Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections. J Clin Microbiol (1983) 1.51
In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol (1974) 1.47
Biochemical fingerprinting of water coliform bacteria, a new method for measuring phenotypic diversity and for comparing different bacterial populations. Appl Environ Microbiol (1991) 1.47
Probiotics and gastrointestinal diseases. J Intern Med (2005) 1.47
Chronic meningitis caused by a penicillin-sensitive microorganism? Lancet (1983) 1.46
Characterization of three different beta-lactamases from the Bacteroides fragilis group. Antimicrob Agents Chemother (1980) 1.45
The role of antibodies against alpha-toxin and teichoic acid in the diagnosis of staphylococcal infections. Infection (1983) 1.45
Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrob Agents Chemother (1992) 1.45
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine (1990) 1.43
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin. Scand J Gastroenterol (1998) 1.40
Determination of toxin-induced leakage of different-size nucleotides through the plasma membrane of human diploid fibroblasts. Infect Immun (1975) 1.39
Separation and characterization of enterotoxin and two haemolysins from Aeromonas hydrophila. Acta Pathol Microbiol Scand B (1981) 1.38
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand J Infect Dis (2001) 1.37
Resistance to beta-lactam antibiotics in Bacteroides species. J Antimicrob Chemother (1981) 1.36
Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother (1974) 1.35
Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin). J Clin Microbiol (1987) 1.35
Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med (1984) 1.34
Receptors for pyelonephritogenic Escherichia coli in primates. J Urol (1984) 1.34
Relapsing clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet (1983) 1.33
The normal human anaerobic microflora. Scand J Infect Dis Suppl (1982) 1.33
Virulence factors in Escherichia coli strains isolated from Swedish piglets with diarrhea. J Clin Microbiol (1988) 1.32
Detection and quantitation by lysis-filtration of bacteremia after different oral surgical procedures. J Clin Microbiol (1990) 1.32
In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline. Clin Microbiol Infect (2000) 1.31
Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect (2009) 1.31
Occurrence, diversity, and pathogenicity of halophilic Vibrio spp. and non-O1 Vibrio cholerae from estuarine waters along the Italian Adriatic coast. Appl Environ Microbiol (1999) 1.30
In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics. Scand J Infect Dis (1974) 1.29
Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis (1986) 1.28
Purification of phospholipase C (alpha-toxin) from Clostridium perfringens. Biochim Biophys Acta (1973) 1.28
Numerical taxonomy and laboratory identification of Actinomyces and Arachnia and some related bacteria. J Gen Microbiol (1975) 1.27
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis (2000) 1.27
Serological studies of Actinomyces israelii by crossed immunoelectrophoresis: taxonomic and diagnostic applications. Infect Immun (1975) 1.27
Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis (1991) 1.27
Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods (1995) 1.27
Effect of cefoperazone on faecal flora. J Antimicrob Chemother (1983) 1.26
Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol (1980) 1.26
Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis (1993) 1.26
Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria. Eur J Clin Microbiol Infect Dis (1989) 1.26
Norfloxacin binds to human fecal material. Antimicrob Agents Chemother (1988) 1.25
Studies on Escherichia coli in pigs V. Determination of enterotoxicity and frequency of O groups and K 88 antigen in strains from 200 piglets with neonatal diarrhoea. Zentralbl Veterinarmed B (1978) 1.25
The role of Bacteroides fragilis in the pathogenesis of acute appendicitis. Acta Chir Scand (1982) 1.25
Antibiotic susceptibility of Clostridium species isolated from human infections. Scand J Infect Dis (1975) 1.25
Phenotypic characterization of intestinal Escherichia coli of pigs during suckling, postweaning, and fattening periods. Appl Environ Microbiol (1995) 1.24
Phenotypic variations among enterotoxinogenic Escherichia coli from Swedish piglets with diarrhoea. Med Microbiol Immunol (1985) 1.24
Characterization of three Aeromonas and nine pseudomonas species by extracellular enzymes and haemolysins. Med Microbiol Immunol (1975) 1.22
European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect (2005) 1.22
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother (1986) 1.20
The effect of zinc oxide supplementation on the stability of the intestinal flora with special reference to composition of coliforms in weaned pigs. J Appl Microbiol (1999) 1.20
Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience. Rev Infect Dis (1985) 1.20
Phenomenon of hot-cold hemolysis: chelator-induced lysis of sphingomyelinase-treated erythrocytes. Infect Immun (1975) 1.19
Classification of microbial, plant and animal cytolysins based on their membrane-damaging effects of human fibroblasts. Biochim Biophys Acta (1979) 1.19